Search Results - "Janković, Gradimir"

Refine Results
  1. 1

    Significance of cytogenetic-risk categories and refined international prognostic scoring system for overall survival in primary myelofibrosis: A single-center experience by Djordjevic, Vesna, Dencic-Fekete, Marija, Jovanovic, Jelica, Soldatovic, Ivan, Jankovic, Gradimir, Bogdanovic, Andrija

    Published in Vojnosanitetski pregled (2020)
    “…Abstract Background/Aim. Primary myelofibrosis (PMF) is a chronic, malignant hematological disease characterized by a leucoerythroblastic blood picture,…”
    Get full text
    Journal Article
  2. 2

    Thirty patients with primary plasma cell leukemia: a single center experience by Čolović, Milica, Janković, Gradimir, Suvajdžić, Nada, Milić, Nataša, Đorđević, Vesna, Janković, Snežana

    “…The primary plasma cell leukemia (PCL) is a rare aggressive plasma cell dyscrasia. We investigated its clinical and laboratory aspects in a large series of…”
    Get full text
    Journal Article
  3. 3

    t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia by Denčić-Fekete, Marija, Đorđević, Vesna, Storlazzi, Clelia Tiziana, Janković, Gradimir, Bogdanović, Andrija, Jovanović, Jelica, Rocchi, Mariano, Todorić-Živanović, Biljana, Strnad, Milica, Gotić, Mirjana

    Published in International journal of hematology (01-05-2009)
    “…A patient with t(9;22)-positive chronic myelogenous leukemia (CML) developed a resistance to therapy with imatinib mesylate (Glivec) which coincided with the…”
    Get full text
    Journal Article
  4. 4

    Favourable prognostic factors in therapy related acute myeloid leukaemia by Antonijevic, Nebojsa, Suvajdzic, Nada, Terzic, Tatjana, Jakovljevic, Branko, Jankovic, Gradimir, Elezovic, Ivo, Milosevic, Rajko, Colovic, Milica

    Published in Srpski arhiv za celokupno lekarstvo (01-05-2011)
    “…Therapy related acute myeloid leukaemia (t-AML) is a distinct clinical entity recognized by the World Health Organization classification occurring after…”
    Get full text
    Journal Article
  5. 5

    Diagnosis and the treatment of primary amyloidosis by Djunić, Irena, Tomin, Dragica, Perunicić, Maja, Vidović, Ana, Cemerikić, Vesna, Djurasinović, Vladislava, Jaković, Ljubomir, Janković, Gradimir

    Published in Vojnosanitetski pregled (01-09-2010)
    “…Primary amyloidosis belongs to a group of monoclonal plasma cell disorders, characterized by extracellular deposition of immunoglobulin light chain fibrils in…”
    Get full text
    Journal Article
  6. 6

    Prognostic significance of cellular vascular endothelial growth factor (VEGF) expression in the course of chronic myeloid leukaemia by Vidović, Ana, Janković, Gradimir, Tomin, Dragica, Perunicić-Jovanović, Maja, Djunić, Irena, Djurasinović, Vladislava, Colović, Milica

    Published in Srpski arhiv za celokupno lekarstvo (01-07-2009)
    “…Increased angiogenesis in bone marrow is one of the characteristics of chronic myeloid leukaemia (CML), a clonal myeloproliferative disorder that expresses a…”
    Get full text
    Journal Article
  7. 7

    Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia by Jurišić, Vladimir, Pavlović, Sonja, Čolović, Nataša, Djordjevic, Vesna, Bunjevački, Vera, Janković, Gradimir, Čolović, Milica

    Published in Journal of genetics (01-08-2009)
    “…Patients with de novo acute myeloid leukemia (AML) and near-tetraploid or completely tetraploid karyotype at presentation are rare. We present four patients…”
    Get full text
    Journal Article
  8. 8

    The proto-oncogene expression varies over the course of chronic myeloid leukemia by Vidović, Ana, Janković, Gradimir, Colović, Milica, Tomin, Dragica, Perunicić, Maja, Bila, Jelena, Marković, Olivera, Bosković, Darinka

    Published in Hematology (Luxembourg) (01-02-2008)
    “…The chronic phase (CP) of chronic myeloid leukemia (CML) is characterized by the expression of chimeric BCR/ABL gene, extended survival, and profligate growth…”
    Get more information
    Journal Article
  9. 9

    Alexander I. Ignatowski: a pioneer in the study of atherosclerosis by Konstantinov, Igor E, Jankovic, Gradimir M

    Published in Texas Heart Institute journal (2013)
    “…In 1908, Alexander I. Ignatowski (1875-1955) published his pioneering work that first revealed a relationship between cholesterol-rich food and experimental…”
    Get full text
    Journal Article
  10. 10

    Sex differences in the incidence of chronic myeloid leukemia by Radivoyevitch, Tomas, Jankovic, Gradimir M., Tiu, Ramon V., Saunthararajah, Yogen, Jackson, Robert C., Hlatky, Lynn R., Gale, Robert Peter, Sachs, Rainer K.

    Published in Radiation and environmental biophysics (01-03-2014)
    “…The incidence of chronic myeloid leukemia (CML), which is caused by BCR/ABL chimeric oncogene formation in a pluripotent hematopoietic stem cell (HSC),…”
    Get full text
    Journal Article
  11. 11

    Diagnostic Challenges during Pretreatment Long-term Follow-up in a Patient with FIP1L1-PDGFRA-positive Eosinophilia by Lekovic, Danijela, Bogdanovic, Andrija, Perunicic-Jovanovic, Maja, Jankovic, Gradimir, Gotic, Mirjana, Elezovic, Ivo

    Published in Internal Medicine (01-01-2015)
    “…Obtaining a precise characterization of eosinophilia is crucial, as successful treatment relies on the underlying etiology of the disease. Platelet-derived…”
    Get full text
    Journal Article
  12. 12

    Pattern of trisomy 1q in hematological malignancies: a single institution experience by Djordjevic, Vesna, Dencic-Fekete, Marija, Jovanovic, Jelica, Drakulic, Danijela, Stevanovic, Milena, Jankovic, Gradimir, Gotic, Mirjana

    Published in Cancer genetics and cytogenetics (01-10-2008)
    “…Abstract An extra copy of 1q usually originates from the translocated unbalanced derivative chromosome, isochromosome, or “jumping translocation.” We report a…”
    Get full text
    Journal Article
  13. 13

    Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia by COLOVIC, M. D, JANKOVIC, G. M, ELEZOVIC, I, VIDOVIC, A, BILA, J. S, NOVAK, A, BABIC, D

    “…Between February 1992 and November 1996 we treated 30 newly diagnosed acute promyelocytic leukaemia (APL) patients either with oral all-trans-retinoic acid…”
    Get full text
    Journal Article
  14. 14

    Size of the protein-coding genome and rate of molecular evolution by Rajic, Zoran A, Jankovic, Gradimir M, Vidovic, Ana, Milic, Natasa M, Skoric, Dejan, Pavlovic, Milorad, Lazarevic, Vladimir

    Published in Journal of human genetics (01-05-2005)
    “…In diploid populations of size N, there will be 2 Nmu mutations per nucleotide (nt) site (or per locus) per generation (mu stands for mutation rate). If either…”
    Get full text
    Journal Article
  15. 15

    Hairy cell leukemia in first cousins and review of the literature by Colovic, Milica D., Jankovic, Gradimir M., Wiernik, Peter H.

    Published in European journal of haematology (01-09-2001)
    “…: Familial hairy cell leukemia (HCL) occurs rarely. So far, 26 familial instances of HCL (in 12 families) have been reported in the literature. The consistent…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Rates of nucleotide substitution, mutation at a locus, and the "beanbag" gene number in man by Jankovic, Gradimir, Pavlovic, Milorad, Lazarevic, Vladimir, Vukomanovic, Djordje

    Published in Journal of human genetics (01-01-2002)
    “…We estimated the number of different human genes by relating the patterns of spontaneous mutation at the population and individual level. A geometric…”
    Get full text
    Journal Article
  17. 17

    Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis by Lekovic, Danijela, Gotic, Mirjana, Perunicic-Jovanovic, Maja, Vidovic, Ana, Bogdanovic, Andrija, Jankovic, Gradimir, Cokic, Vladan, Milic, Natasa

    “…The widely used current International Prognostic Scoring System (IPSS) for primary myelofibrosis (PMF) is based on clinical parameters. The objective of this…”
    Get full text
    Journal Article
  18. 18

    Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients by Colovic, Milica, Colovic, Natasa, Radojkovic, Milica, Stanisavljevic, Dejana, Kraguljac, Nada, Jankovic, Gradimir, Tomin, Dragica, Suvajdzic, Nada, Vidovic, Ana, Atkinson, Henry Dushan

    Published in Annals of hematology (01-09-2012)
    “…A retrospective survey of 210 consecutive patients aged ≥65 years (median age 69 years, range 65–88 years) with acute myeloid leukemia (AML) diagnosed at a…”
    Get full text
    Journal Article
  19. 19

    More than a third of non-gastric malt lymphomas are disseminated at diagnosis: a single center survey by Sretenovic, Mirjana, Colovic, Milica, Jankovic, Gradimir, Suvajdzic, Nada, Mihaljevic, Biljana, Colovic, Natasa, Todorovic, Milena, Atkinson, Henry Dushan E.

    Published in European journal of haematology (01-05-2009)
    “…Mucosa‐associated lymphoid tissue (MALT) lymphomas are extranodal B‐cell tumors that generally follow an indolent course. The gastrointestinal tract is the…”
    Get full text
    Journal Article
  20. 20

    Osteolytic lesions marker in multiple myeloma by Djunic, Irena, Elezovic, Ivo, Marinkovic, Milica, Suvajdzic-Vukovic, Nada, Tomin, Dragica, Jankovic, Gradimir, Bila, Jelena, Antic, Darko, Vidovic, Ana, Neskovic, Borka, Nikolic-Vukosavljevic, Dragica

    “…The degradation product of collagen type I carboxy terminal telopeptide (ICTP) represents a new biochemical parameter that reflects the changes in the…”
    Get full text
    Journal Article